Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1569 ARTÍCULOS , VIENDO DEL 1291 AL 1305

Obstructive sleep apnoea and Alzheimer's disease: In search of shared pathomechanisms

Polsek D, Gildeh N, Cash D, Winsky-Sommerer R, Williams SCR, Turkheimer F, Leschziner GD, Morrell MJ, Rosenzweig I.

Neurosci Biobehav Rev. 2018 Mar;86:142-149. doi: 10.1016/j.neubiorev.2017.12.004. Epub 2017 Dec 7.

Comparison of blood-brain barrier penetration efficiencies between linear and cyclic all-d-enantiomeric peptides developed for the treatment of Alzheimer's disease

Schartmann E, Schemmert S, Ziehm T, Leithold LHE, Jiang N, Tusche M, Joni Shah N, Langen KJ, Kutzsche J, Willbold D, Willuweit A.

Eur J Pharm Sci. 2018 Mar 1;114:93-102. doi: 10.1016/j.ejps.2017.12.005. Epub 2017 Dec 7.

Reactive astrocytes in Alzheimer's disease: A double-edged sword

Chun H, Lee CJ.

Neurosci Res. 2018 Jan;126:44-52. doi: 10.1016/j.neures.2017.11.012. Epub 2017 Dec 7.

Amylin in Alzheimer's disease: Pathological peptide or potential treatment?

Mietlicki-Baase EG.

Neuropharmacology. 2018 Jul 1;136(Pt B):287-297. doi: 10.1016/j.neuropharm.2017.12.016. Epub 2017 Dec 9.

Alzheimer's disease and gut microbiota modifications: The long way between preclinical studies and clinical evidence

Mancuso C, Santangelo R.

Pharmacol Res. 2018 Mar;129:329-336. doi: 10.1016/j.phrs.2017.12.009. Epub 2017 Dec 9.

Suvorexant for the treatment of insomnia in patients with Alzheimer's disease

Hamuro A, Honda M, Wakaura Y.

Aust N Z J Psychiatry. 2018 Feb;52(2):207-208. doi: 10.1177/0004867417747402. Epub 2017 Dec 14.

Does traumatic brain injury hold the key to the Alzheimer's disease puzzle?

Becker RE, Kapogiannis D, Greig NH.

Alzheimers Dement. 2018 Apr;14(4):431-443. doi: 10.1016/j.jalz.2017.11.007. Epub 2017 Dec 12.

Functional dissection of astrocyte-secreted proteins: Implications in brain health and diseases

Jha MK, Kim JH, Song GJ, Lee WH, Lee IK, Lee HW, An SSA, Kim S, Suk K.

Prog Neurobiol. 2018 Mar;162:37-69. doi: 10.1016/j.pneurobio.2017.12.003. Epub 2017 Dec 13.

Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer's disease

Sahoo AK, Dandapat J, Dash UC, Kanhar S.

J Ethnopharmacol. 2018 Apr 6;215:42-73. doi: 10.1016/j.jep.2017.12.015. Epub 2017 Dec 14.

CSF β-amyloid and white matter damage: unravelling the neuropathology of Alzheimer's disease

Sousa Alves G.

J Neurol Neurosurg Psychiatry. 2018 Apr;89(4):329. doi: 10.1136/jnnp-2017-317053. Epub 2017 Dec 16.

Tramadol ameliorates behavioural, biochemical, mitochondrial and histological alterations in ICV-STZ-induced sporadic dementia of Alzheimer's type in rats

Dhull DK, Kumar A.

Inflammopharmacology. 2018 Aug;26(4):925-938. doi: 10.1007/s10787-017-0431-3. Epub 2017 Dec 16.

Cinnamon, a promising prospect towards Alzheimer's disease

Momtaz S, Hassani S, Khan F, Ziaee M, Abdollahi M.

Pharmacol Res. 2018 Apr;130:241-258. doi: 10.1016/j.phrs.2017.12.011. Epub 2017 Dec 16.

Emerging Roles of Sirtuin 6 in Alzheimer's Disease

Mohamad Nasir NF, Zainuddin A, Shamsuddin S.

J Mol Neurosci. 2018 Feb;64(2):157-161. doi: 10.1007/s12031-017-1005-y. Epub 2017 Dec 19.

Caenorhabditis elegans: A Convenient In Vivo Model for Assessing the Impact of Food Bioactive Compounds on Obesity, Aging, and Alzheimer's Disease

Shen P, Yue Y, Zheng J, Park Y.

Annu Rev Food Sci Technol. 2018 Mar 25;9:1-22. doi: 10.1146/annurev-food-030117-012709. Epub 2017 Dec 20.

Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders

Augustin K, Khabbush A, Williams S, Eaton S, Orford M, Cross JH, Heales SJR, Walker MC, Williams RSB.

Lancet Neurol. 2018 Jan;17(1):84-93. doi: 10.1016/S1474-4422(17)30408-8. Epub 2017 Dec 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias